Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer

NCT00278460 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: docetaxel
DRUG: gemcitabine hydrochloride

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]